Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor–positive advanced breast cancer

অনুযায়ী Beck, J Thaddeus
প্রকাশিত Onco Targets Ther (2015)

A Case of Disease Improvement after Treatment with Everolimus plus Exemestane in a Patient with Hormone Receptor-Positive Metastatic Breast Cancer with Bone Metastases

অনুযায়ী Beck, J. Thaddeus, Mantooth, Ryan
প্রকাশিত Case Rep Oncol (2015)

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study

অনুযায়ী Piha-Paul, Sarina A., Taylor, Matthew H., Spitz, Daniel, Schwartzberg, Lee, Beck, J. Thaddeus, Bauer, Todd M., Meric-Bernstam, Funda, Purkayastha, Das, Karpiak, Linda, Szpakowski, Sebastian, Braiteh, Fadi
প্রকাশিত Oncotarget (2019)

Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study

অনুযায়ী Hernandez Puente, Cinthia Violeta, Hsu, Ping-Ching, Rogers, Lora J., Jousheghany, Fariba, Siegel, Eric, Kadlubar, Susan A., Beck, J. Thaddeus, Makhoul, Issam, Hutchins, Laura F., Kieber-Emmons, Thomas, Monzavi-Karbassi, Behjatolah
প্রকাশিত Front Oncol (2020)

Phase 1B/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen

অনুযায়ী Kong, Anthony, Rea, Daniel, Ahmed, Samreen, Beck, J. Thaddeus, López, Rafael López, Biganzoli, Laura, Armstrong, Anne C., Aglietta, Massimo, Alba, Emilio, Campone, Mario, Schmitz, Shu-Fang Hsu, Lefebvre, Caroline, Akimov, Mikhail, Lee, Soo-Chin
প্রকাশিত Oncotarget (2016)

A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer

অনুযায়ী Gorbunova, Vera, Beck, J. Thaddeus, Hofheinz, Ralf-Dieter, Garcia-Alfonso, Pilar, Nechaeva, Marina, Cubillo Gracian, Antonio, Mangel, Laszlo, Elez Fernandez, Elena, Deming, Dustin A., Ramanathan, Ramesh K., Torres, Alison H., Sullivan, Danielle, Luo, Yan, Berlin, Jordan D.
প্রকাশিত Br J Cancer (2018)

Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer

অনুযায়ী Gorbunova, Vera, Beck, J. Thaddeus, Hofheinz, Ralf-Dieter, Garcia-Alfonso, Pilar, Nechaeva, Marina, Gracian, Antonio Cubillo, Mangel, Laszlo, Fernandez, Elena Elez, Deming, Dustin A., Ramanathan, Ramesh K., Torres, Alison H., Sullivan, Danielle, Luo, Yan, Berlin, Jordan D.
প্রকাশিত Br J Cancer (2019)

Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study

অনুযায়ী Fasching, Peter A., Beck, J. Thaddeus, Chan, Arlene, De Laurentiis, Michele, Esteva, Francisco J., Jerusalem, Guy, Neven, Patrick, Pivot, Xavier, Bianchi, Giulia V., Martin, Miguel, Chandiwana, David, Lanoue, Brad, Ridolfi, Antonia, Wang, Yingbo, Rodriguez Lorenc, Karen, Nusch, Arnd
প্রকাশিত Breast (2020)

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

অনুযায়ী Hart, Lowell L., Ferrarotto, Renata, Andric, Zoran G., Beck, J. Thaddeus, Subramanian, Janakiraman, Radosavljevic, Davorin Z., Zaric, Bojan, Hanna, Wahid T., Aljumaily, Raid, Owonikoko, Taofeek K., Verhoeven, Didier, Xiao, Jie, Morris, Shannon R., Antal, Joyce M., Hussein, Maen A.
প্রকাশিত Adv Ther (2020)

Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer

অনুযায়ী Hingorani, Sunil R., Harris, William P., Beck, J. Thaddeus, Berdov, Boris A., Wagner, Stephanie A., Pshevlotsky, Eduard M., Tjulandin, Sergei A., Gladkov, Oleg A., Holcombe, Randall F., Korn, Ronald, Raghunand, Natarajan, Dychter, Samuel, Jiang, Ping, Shepard, H. Michael, Devoe, Craig E.
প্রকাশিত Clin Cancer Res (2016)

Everolimus plus exemestane as first-line therapy in HR(+), HER2(−) advanced breast cancer in BOLERO-2

অনুযায়ী Beck, J. Thaddeus, Hortobagyi, Gabriel N., Campone, Mario, Lebrun, Fabienne, Deleu, Ines, Rugo, Hope S., Pistilli, Barbara, Masuda, Norikazu, Hart, Lowell, Melichar, Bohuslav, Dakhil, Shaker, Geberth, Matthias, Nunzi, Martina, Heng, Daniel Y. C., Brechenmacher, Thomas, El-Hashimy, Mona, Douma, Shyanne, Ringeisen, Francois, Piccart, Martine
প্রকাশিত 2013

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma

অনুযায়ী van Herpen, Carla M.L., Agarwala, Sanjiv S., Hauschild, Axel, Berking, Carola, Beck, J. Thaddeus, Schadendorf, Dirk, Jansen, Rob, Queirolo, Paola, Ascierto, Paolo A., Blank, Christian U., Heinrich, Michael C., Pal, Rupam R., Derti, Adnan, Antona, Victor, Nauwelaerts, Heidi, Zubel, Angela, Dummer, Reinhard
প্রকাশিত Oncotarget (2019)

Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine...

অনুযায়ী Hurwitz, Herbert I., Uppal, Nikhil, Wagner, Stephanie A., Bendell, Johanna C., Beck, J. Thaddeus, Wade, Seaborn M., Nemunaitis, John J., Stella, Philip J., Pipas, J. Marc, Wainberg, Zev A., Manges, Robert, Garrett, William M., Hunter, Deborah S., Clark, Jason, Leopold, Lance, Sandor, Victor, Levy, Richard S.
প্রকাশিত J Clin Oncol (2015)

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial

অনুযায়ী Disis, Mary L., Taylor, Matthew H., Kelly, Karen, Beck, J. Thaddeus, Gordon, Michael, Moore, Kathleen M., Patel, Manish R., Chaves, Jorge, Park, Haeseong, Mita, Alain C., Hamilton, Erika P., Annunziata, Christina M., Grote, Hans Juergen, von Heydebreck, Anja, Grewal, Jaspreet, Chand, Vikram, Gulley, James L.
প্রকাশিত JAMA Oncol (2019)

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

অনুযায়ী Baselga, José, Campone, Mario, Piccart, Martine, Burris, Howard A., Rugo, Hope S., Sahmoud, Tarek, Noguchi, Shinzaburo, Gnant, Michael, Pritchard, Kathleen I., Lebrun, Fabienne, Beck, J. Thaddeus, Ito, Yoshinori, Yardley, Denise, Deleu, Ines, Perez, Alejandra, Bachelot, Thomas, Vittori, Luc, Xu, Zhiying, Mukhopadhyay, Pabak, Lebwohl, David, Hortobagyi, Gabriel N.
প্রকাশিত N Engl J Med (2011)

A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in advanced clear cell renal cell carcinoma

অনুযায়ী Voss, Martin H., Bhatt, Rupal S., Vogelzang, Nicholas J., Fishman, Mayer, Alter, Robert S., Rini, Brian I., Beck, J. Thaddeus, Joshi, Monika, Hauke, Ralph, Atkins, Michael B., Burgess, Earle, Logan, Theodore F., Shaffer, David, Parikh, Rahul, Moazzam, Nauman, Zhang, Xiaosha, Glasser, Chad, Sherman, Matthew L., Plimack, Elizabeth R.
প্রকাশিত Cancer (2019)

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed...

অনুযায়ী Zinner, Ralph G., Obasaju, Coleman K., Spigel, David R., Weaver, Robert W., Beck, J. Thaddeus, Waterhouse, David M., Modiano, Manuel R., Hrinczenko, Borys, Nikolinakos, Petros G., Liu, Jingyi, Koustenis, Andrew G., Winfree, Katherine B., Melemed, Symantha A., Guba, Susan C., Ortuzar, Waldo I., Desaiah, Durisala, Treat, Joseph A., Govindan, Ramaswamy, Ross, Helen J.
প্রকাশিত J Thorac Oncol (2015)

Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Re...

অনুযায়ী Motzer, Robert J., Barrios, Carlos H., Kim, Tae Min, Falcon, Silvia, Cosgriff, Thomas, Harker, W. Graydon, Srimuninnimit, Vichien, Pittman, Ken, Sabbatini, Roberto, Rha, Sun Young, Flaig, Thomas W., Page, Ray, Bavbek, Sevil, Beck, J. Thaddeus, Patel, Poulam, Cheung, Foon-yiu, Yadav, Sunil, Schiff, Edward M., Wang, Xufang, Niolat, Julie, Sellami, Dalila, Anak, Oezlem, Knox, Jennifer J.
প্রকাশিত J Clin Oncol (2014)